211 related articles for article (PubMed ID: 34041914)
1. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
[TBL] [Abstract][Full Text] [Related]
2. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
3. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
Qian F; Huang J; Hussain MA
J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
[TBL] [Abstract][Full Text] [Related]
4. Tailoring supersaturation from amorphous solid dispersions.
Li N; Taylor LS
J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
[TBL] [Abstract][Full Text] [Related]
5. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
Meng F; Dave V; Chauhan H
Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
[TBL] [Abstract][Full Text] [Related]
7. Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.
Lin X; Hu Y; Liu L; Su L; Li N; Yu J; Tang B; Yang Z
Pharm Res; 2018 Apr; 35(6):125. PubMed ID: 29687226
[TBL] [Abstract][Full Text] [Related]
8. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
9. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
10. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
[TBL] [Abstract][Full Text] [Related]
11. A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations.
Kyeremateng SO; Pudlas M; Woehrle GH
J Pharm Sci; 2014 Sep; 103(9):2847-2858. PubMed ID: 24634063
[TBL] [Abstract][Full Text] [Related]
12. Investigating crystallization tendency, miscibility, and molecular interactions of drug-polymer systems for the development of amorphous solid dispersions.
Meng F; Paul SK; Borde S; Chauhan H
Drug Dev Ind Pharm; 2021 Apr; 47(4):579-608. PubMed ID: 33651659
[TBL] [Abstract][Full Text] [Related]
13. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
14. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
Hu Z; Xu P; Ashour EA; Repka MA
AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
[TBL] [Abstract][Full Text] [Related]
15. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
16. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
Xi L; Song H; Wang Y; Gao H; Fu Q
AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling as a predictive tool for the development of solid dispersions.
Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
[TBL] [Abstract][Full Text] [Related]
18. Novel Thermal Imaging Method for Rapid Screening of Drug-Polymer Miscibility for Solid Dispersion Based Formulation Development.
Alhijjaj M; Belton P; Fábián L; Wellner N; Reading M; Qi S
Mol Pharm; 2018 Dec; 15(12):5625-5636. PubMed ID: 30372612
[TBL] [Abstract][Full Text] [Related]
19. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
Marsac PJ; Li T; Taylor LS
Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
[TBL] [Abstract][Full Text] [Related]
20. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
Dalsania S; Sharma J; Munjal B; Bansal AK
Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]